CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
36.95
+0.66 (1.82%)
At close: Jun 2, 2025, 4:00 PM
37.19
+0.24 (0.65%)
After-hours: Jun 2, 2025, 7:54 PM EDT

CRISPR Therapeutics AG Market Cap

CRISPR Therapeutics AG has a market cap or net worth of $3.19 billion as of June 2, 2025. Its market cap has decreased by -32.55% in one year.

Market Cap
3.19B
Enterprise Value
1.56B
1-Year Change
-32.55%
Ranking
Category
Stock Price
$36.95

Market Cap Chart

Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $3.19B, an increase of 469.74%. That is a compound annual growth rate of 22.38%.

History

DateMarket Cap% Change
May 30, 20253.13B-6.71%
Dec 31, 20243.36B-32.44%
Dec 29, 20234.97B56.24%
Dec 30, 20223.18B-45.12%
Dec 31, 20215.80B-46.39%
Dec 31, 202010.82B221.74%
Dec 31, 20193.36B126.76%
Dec 31, 20181.48B53.95%
Dec 29, 2017963.10M19.42%
Dec 30, 2016806.50M43.99%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 668.09B
Johnson & Johnson 371.11B
AbbVie 328.44B
Novo Nordisk 305.07B
UnitedHealth Group 275.65B
Abbott Laboratories 231.49B
AstraZeneca 224.00B
Novartis AG 223.92B
Market Cap Rankings